Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia
Author
Abstract
Suggested Citation
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Van Tielen, Rudy & Peys, Frank & Genaert, Jean, 1998. "The demographic impact on ambulatory pharmaceutical expenditure in Belgium," Health Policy, Elsevier, vol. 45(1), pages 1-14, July.
- Evans, R.G. & McGrail, K.M. & Morgan, S.G. & Barer, M.L. & Hertzman, C., 2001. "Apocalypse No: Population Aging and the Future of Health Care Systems," Centre for Health Services and Policy Research 2001:3r, University of British Columbia - Centre for Health Services and Policy Research..
- R.G. Evans & K.M. McGrail & S.G. Morgan & M.L. Barer & C. Hertzman, 2001. "APOCALYPSE NO: Population Aging and the Future of Health Care Systems," Social and Economic Dimensions of an Aging Population Research Papers 59, McMaster University.
- Mueller, C. & Schur, C. & O'Connell, J., 1997. "Prescription drug spending: The impact of age and chronic disease status," American Journal of Public Health, American Public Health Association, vol. 87(10), pages 1626-1629.
- Paul Grootendorst & Laurie Goldsmith & Jeremiah Hurley & Bernie O'Brien & Lisa Dolovich, 1996. "Financial Incentives to Dispense Low-Cost Drugs: A Case Study of British Columbia Pharmacare," Centre for Health Economics and Policy Analysis Working Paper Series 1996-08, Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Andersson, Karolina & Bergstrom, Gina & Petzold, Max G. & Carlsten, Anders, 2007. "Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals," Health Policy, Elsevier, vol. 81(2-3), pages 376-384, May.
- Colin Busby & Jonathan Pedde, 2014. "Should Public Drug Plans be Based on Age or Income?," C.D. Howe Institute Commentary, C.D. Howe Institute, issue 417, November.
- Burapadaja, Siriporn & Kawasaki, Naohito & Charumanee, Suporn & Ogata, Fumihiko, 2007. "Effects of essential medicines on cardiovascular products available for the market in Thailand," Health Policy, Elsevier, vol. 84(1), pages 67-74, November.
- Mousnad, Mohamed Awad & Shafie, Asrul Akmal & Ibrahim, Mohamed Izham, 2014. "Systematic review of factors affecting pharmaceutical expenditures," Health Policy, Elsevier, vol. 116(2), pages 137-146.
- Lambrelli, Dimitra & O'Donnell, Owen, 2011. "The impotence of price controls: Failed attempts to constrain pharmaceutical expenditures in Greece," Health Policy, Elsevier, vol. 101(2), pages 162-171, July.
- Håkonsen, Helle & Horn, Anne Marie & Toverud, Else-Lydia, 2009. "Price control as a strategy for pharmaceutical cost containment--What has been achieved in Norway in the period 1994-2004?," Health Policy, Elsevier, vol. 90(2-3), pages 277-285, May.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Fabio Pammolli & Francesco Porcelli & Francesco Vidoli & Monica Auteri & Guido Borà, 2017. "La spesa sanitaria delle Regioni in Italia - Saniregio2017," Working Papers CERM 01-2017, Competitività, Regole, Mercati (CERM).
- Jean-Luc Heeb & Véronique Haberey-Knuessi, 2014. "Health Professionals Facing Burnout: What Do We Know about Nursing Managers?," Nursing Research and Practice, Hindawi, vol. 2014, pages 1-7, April.
- J.C. Herbert Emery, 2010.
"Understanding the Political Economy of the Evolution and Future of Single-Payer Public Health Insurance in Canada,"
SPP Briefing Papers, The School of Public Policy, University of Calgary, vol. 3(2), February.
- J.C. Herbert Emery, 2010. "Understanding the Political Economy of the Evolution and Future of Single-Payer Public Health Insurance in Canada," SPP Technical Papers, The School of Public Policy, University of Calgary, February.
- Constantina Safiliou-Rothschild, 2009. "Are Older People Responsible for High Healthcare Costs?," CESifo Forum, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 10(01), pages 57-64, April.
- Berta, Whitney & Laporte, Audrey & Zarnett, Dara & Valdmanis, Vivian & Anderson, Geoffrey, 2006. "A pan-Canadian perspective on institutional long-term care," Health Policy, Elsevier, vol. 79(2-3), pages 175-194, December.
- William Robson & Colin Busby & Aaron Jacobs, 2014. "Managing Healthcare for an Aging Population: Ontario’s Troubling Collision Course," e-briefs 192, C.D. Howe Institute.
- Mousnad, Mohamed Awad & Shafie, Asrul Akmal & Ibrahim, Mohamed Izham, 2014. "Systematic review of factors affecting pharmaceutical expenditures," Health Policy, Elsevier, vol. 116(2), pages 137-146.
- Peine, Alexander & Rollwagen, Ingo & Neven, Louis, 2014. "The rise of the “innosumer”—Rethinking older technology users," Technological Forecasting and Social Change, Elsevier, vol. 82(C), pages 199-214.
- Ethel Yiranbon & Zhou Lulin & Henry Asante Antwi & Emmanuel Opoku Marfo & Kwame Oduro Amoako & Daniel Kwame Offin, 2014. "Evaluating the Consequences of Ageing Population on Healthcare Cost to Ghana using Inflation-Adjusted Expenditure and Demographic Factors," International Journal of Academic Research in Accounting, Finance and Management Sciences, Human Resource Management Academic Research Society, International Journal of Academic Research in Accounting, Finance and Management Sciences, vol. 4(2), pages 282-290, April.
- Frank T. Denton & Byron G. Spencer, 2003.
"Population Change and Economic Growth: The Long-Term Outlook,"
Social and Economic Dimensions of an Aging Population Research Papers
102, McMaster University.
- Frank T. Denton & Byron G. Spencer, 2003. "Population Change and Economic Growth: The Long-Term Outlook," Quantitative Studies in Economics and Population Research Reports 383, McMaster University.
- Constantina Safiliou-Rothschild, 2009. "Are Older People Responsible for High Healthcare Costs?," CESifo Forum, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 10(1), pages 57-64, April.
- Peine & Ingo Rollwagen & Louis Neven, 2012. "Exploring new patterns of user involvement – baby boomers and the future of consumption," Innovation Studies Utrecht (ISU) working paper series 12-09, Utrecht University, Department of Innovation Studies, revised Sep 2012.
- Di Matteo, Livio & Cantarero-Prieto, David, 2018. "The Determinants of Public Health Expenditures: Comparing Canada and Spain," MPRA Paper 87800, University Library of Munich, Germany.
- Brigitte Dormont & Michel Grignon & Hélène Huber, 2006.
"Health expenditure growth: reassessing the threat of ageing,"
Health Economics, John Wiley & Sons, Ltd., vol. 15(9), pages 947-963, September.
- Brigitte Dormont & Michel Grignon & Hélène Huber, 2006. "Health expenditure growth : reassessing the threat of ageing," Post-Print halshs-00181605, HAL.
- William Robson & Colin Busby & Aaron Jacobs, 2015. "Managing Healthcare for an Aging Population: Are Demographics a Fiscal Iceberg for Newfoundland and Labrador?," e-briefs 200, C.D. Howe Institute.
- William Robson & Colin Busby & Aaron Jacobs, 2014. "Healthcare and an Aging Population: Managing Slow-Growing Revenues and Rising Health Spending in British Columbia," e-briefs 195, C.D. Howe Institute.
- Di Matteo, Livio, 2005. "The macro determinants of health expenditure in the United States and Canada: assessing the impact of income, age distribution and time," Health Policy, Elsevier, vol. 71(1), pages 23-42, January.
- Mehrdad Roham & Anait R. Gabrielyan & Norman P. Archer & Michel L. Grignon & Byron G. Spencer, 2014. "The Impact Of Technological Intensity Of Service Provision On Physician Expenditures: An Exploratory Investigation," Health Economics, John Wiley & Sons, Ltd., vol. 23(10), pages 1224-1241, October.
- Gourzoulidis, George & Kourlaba, Georgia & Stafylas, Panagiotis & Giamouzis, Gregory & Parissis, John & Maniadakis, Nikolaos, 2017. "Association between copayment, medication adherence and outcomes in the management of patients with diabetes and heart failure," Health Policy, Elsevier, vol. 121(4), pages 363-377.
- Ernst R. Berndt & Margaret Kyle & Davina Ling, 2003. "The Long Shadow of Patent Expiration. Generic Entry and Rx-to-OTC Switches," NBER Chapters, in: Scanner Data and Price Indexes, pages 229-267, National Bureau of Economic Research, Inc.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:68:y:2004:i:3:p:299-307. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.